Abstract P2-16-13: Phase I dose escalation clinical trial of the PI3K inhibitor BKM120 and capecitabine (C) in metastatic breast cancer (MBC)EC Dees,PK Marcom, A Snavely, J Noe,CK Anders, K Blackwell, G Kimmick, K Reeder-Hayes, D Rosenstein,CM Perou,LA CareyPoster Session Abstracts（2013）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
